Who
Albert Bourla
Chairman & CEO
Company insider
Files Form 4 as: Chairman & CEO, Pfizer.
In numbers
- Trades disclosed
- 475
- Buys
- 1
- Sells
- 2
- Bought
- $2.0M
- Sold
- $6.1M
- Companies
- 1
- Companies where not an officer
- 0
- First trade
- 24 Feb 2014
- Last trade
- 15 Oct 2026
- Last filed
- 16 Oct 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 15 Oct 2026filed 16 Oct 2026 | PFE Pfizeroption or derivative · Pharmaceuticals | SEC FORM 4 Code A | $58920 at $29.44 | filing |
| 13 Oct 2026filed 14 Oct 2026 | PFE Pfizeroption or derivative · Pharmaceuticals | SEC FORM 4 Code A | $2,01471 at $28.37 | filing |
| 30 Sep 2026filed 1 Oct 2026 | PFE Pfizeroption or derivative · Pharmaceuticals | SEC FORM 4 Code A | $59921 at $28.52 | filing |
| 15 Sep 2026filed 16 Sep 2026 | PFE Pfizeroption or derivative · Pharmaceuticals | SEC FORM 4 Code A | $60622 at $27.55 | filing |
| 15 Sep 2026filed 16 Sep 2026 | PFE Pfizeroption or derivative · Pharmaceuticals | SEC FORM 4 Code A | $60622 at $27.55 | filing |
| 31 Aug 2026filed 1 Sep 2026 | PFE Pfizeroption or derivative · Pharmaceuticals | SEC FORM 4 Code A | $59821 at $28.46 | filing |
| 31 Aug 2026filed 1 Sep 2026 | PFE Pfizeroption or derivative · Pharmaceuticals | SEC FORM 4 Code A | $59821 at $28.46 | filing |
| 14 Aug 2026filed 17 Aug 2026 | PFE Pfizeroption or derivative · Pharmaceuticals | SEC FORM 4 Code A | $58922 at $26.79 | filing |
| 14 Aug 2026filed 17 Aug 2026 | PFE Pfizeroption or derivative · Pharmaceuticals | SEC FORM 4 Code A | $58922 at $26.79 | filing |
| 12 Aug 2026filed 12 Aug 2026 | PFE PfizerPharmaceuticals | SEC FORM 4 Bought | $1.0M38,000 at $26.34 | filing |
| 12 Aug 2026filed 12 Aug 2026 | PFE PfizerPharmaceuticals | SEC FORM 4 Bought | $1.0M38,000 at $26.34 | filing |
| 31 Jul 2026filed 3 Aug 2026 | PFE Pfizeroption or derivative · Pharmaceuticals | SEC FORM 4 Code A | $60024 at $25.01 | filing |
| 31 Jul 2026filed 3 Aug 2026 | PFE Pfizeroption or derivative · Pharmaceuticals | SEC FORM 4 Code A | $60024 at $25.01 | filing |
| 15 Jul 2026filed 16 Jul 2026 | PFE Pfizeroption or derivative · Pharmaceuticals | SEC FORM 4 Code A | $59624 at $24.82 | filing |
| 15 Jul 2026filed 16 Jul 2026 | PFE Pfizeroption or derivative · Pharmaceuticals | SEC FORM 4 Code A | $59624 at $24.82 | filing |
| 9 Jul 2026filed 13 Jul 2026 | PFE Pfizeroption or derivative · Pharmaceuticals | SEC FORM 4 Code A | $2,03784 at $24.25 | filing |
| 9 Jul 2026filed 13 Jul 2026 | PFE Pfizeroption or derivative · Pharmaceuticals | SEC FORM 4 Code A | $2,03784 at $24.25 | filing |
| 30 Jun 2026filed 1 Jul 2026 | PFE Pfizeroption or derivative · Pharmaceuticals | SEC FORM 4 Code A | $60225 at $24.08 | filing |
| 30 Jun 2026filed 1 Jul 2026 | PFE Pfizeroption or derivative · Pharmaceuticals | SEC FORM 4 Code A | $60225 at $24.08 | filing |
| 15 Jun 2026filed 16 Jun 2026 | PFE Pfizeroption or derivative · Pharmaceuticals | SEC FORM 4 Code A | $59823 at $26.00 | filing |
News
Florida's Attorney General SUES Pfizer and Albert Bourla for HIDING COVID Shot Deaths, Heart Damage, Miscarriages, and Strokesfreerepublic.com · 8 Oct 2026Florida Files Lawsuit Against Pfizer and CEO Albert Bourla Over Alleged Vaccine Safety Misrepresentationcubaheadlines.com · 4 Oct 2026Pfizer's Dividend Yield Is One of the Highest in the S&P 500. Here's Why the Dividend Is Safer Than It Might SeemPFE · fool.com · 24 Oct 2026Pharmaceutical giant Pfizer cutting jobs at manufacturing plants in Rocky Mount and SanfordPFE · publicradioeast.org · 23 Oct 2026Better Dividend Stock to Buy and Hold: Pfizer or Bristol Myers Squibb?PFE · aol.com · 23 Oct 2026
2 headlines in the last 90 days name Albert Bourla; 3 articles from the last 14 days about the 1 company they traded most, at most three about any one of them.